MET and pancreatic neoplasm: DCLK1 has previously been linked to the pro-oncogenic CSC markers c-MET and c-MYC [21,22], and gene set enrichment analysis demonstrated that DCLK1-IN-1 affected MET-driven oncogenesis in patient-derived pancreatic cancer organoids [17].